Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration (FDA) for bosentan tablets for oral suspension, 32 mg,...
Healthcare chain Rainbow Children’s Medicare Ltd posted a steady December quarter, driven by higher occupancy and steady procedural mix, though margins saw a mild...
Rainbow Children’s Medicare Ltd posted its second-quarter results on Thursday, November 13, reporting a 4.6% year-on-year decline in net profit at ₹75 crore for...